Dr Contreras wrote to Dr Smithies (DHSS) with a proposed study of post transfusion Non-A Non-B hepatitis. Read more about Dr Contreras wrote to Dr Smithies (DHSS) with a proposed study of post transfusion Non-A Non-B hepatitis.
Dr Fraser confirmed to Dr Cash the lack of enthusiasm for a study amongst other regional transfusion directors in England and Wales: only he and Dr Contreras had supported it and the rest of the directors "were not very interested." Read more about Dr Fraser confirmed to Dr Cash the lack of enthusiasm for a study amongst other regional transfusion directors in England and Wales: only he and Dr Contreras had supported it and the rest of the directors "were not very interested."
American Red Cross wrote to Dr Cash in response to his letter to Dr Sandler for an update on surrogate donation testing in the USA. This started after a presentation by Dr Harvey Alter at the 1985 AABB annual meeting. They were also preparing for implementing ALT and anti-HBc testing in blood centers. Read more about American Red Cross wrote to Dr Cash in response to his letter to Dr Sandler for an update on surrogate donation testing in the USA. This started after a presentation by Dr Harvey Alter at the 1985 AABB annual meeting. They were also preparing for implementing ALT and anti-HBc testing in blood centers.
Dr Cash asked Dr Sandler American Red Cross) to enlighten his team on the current state of surrogate donation testing in the USA Read more about Dr Cash asked Dr Sandler American Red Cross) to enlighten his team on the current state of surrogate donation testing in the USA
Dr Cash wrote to Dr Fraser to organise a consensus meeting to discuss NANB surrogate testing methods after Dr Fraser's prospective UK trial was turned down at the NBTS Directors' meeting. Read more about Dr Cash wrote to Dr Fraser to organise a consensus meeting to discuss NANB surrogate testing methods after Dr Fraser's prospective UK trial was turned down at the NBTS Directors' meeting.
Dr Forrester reiterated Dr Dow in stating that the cost to benefit ratio of introducing surrogate screening in the West of Scotland means he would recommend against it. Read more about Dr Forrester reiterated Dr Dow in stating that the cost to benefit ratio of introducing surrogate screening in the West of Scotland means he would recommend against it.
Dr Dow produced a report that stated the introduction of surrogate screening would have little to no impact on reducing the "already low level of NANBH PTH cases at present reported within the West of Scotland region". Read more about Dr Dow produced a report that stated the introduction of surrogate screening would have little to no impact on reducing the "already low level of NANBH PTH cases at present reported within the West of Scotland region".
Dr Gunson was a proponent of the minimum risk to maximum safety concept and concurred with both the opinions of Dr Barbara and Dr Contreras Read more about Dr Gunson was a proponent of the minimum risk to maximum safety concept and concurred with both the opinions of Dr Barbara and Dr Contreras
Mr Justice Burton concludes that the idea of reducing donor numbers that were unwanted was never discussed by ACTTD or ACVSB and neither ALT or HBc testing overlapped. They should have introduced surrogate testing before 1 March 1988. Read more about Mr Justice Burton concludes that the idea of reducing donor numbers that were unwanted was never discussed by ACTTD or ACVSB and neither ALT or HBc testing overlapped. They should have introduced surrogate testing before 1 March 1988.
Mr Justice Burton assessed that the introduction of ALT and anti-HBc testing would have lost 2.5% and 4% of donations respectively but this would have been countered by the moving surplus blood supplies to centres in need. He believed there would not be a major shortage as Dr Gunson had described in 1991. Read more about Mr Justice Burton assessed that the introduction of ALT and anti-HBc testing would have lost 2.5% and 4% of donations respectively but this would have been countered by the moving surplus blood supplies to centres in need. He believed there would not be a major shortage as Dr Gunson had described in 1991.